Amyloid β
Amyloid β denotes peptides of 36–43 amino acids result from the APP (amyloid precursor protein) and are involved in Alzheimer's disease as the main component of the amyloid plaques.
Products for Amyloid β
- Cat.No. Product Name Information
-
BCC1002
Beta-Amyloid (1-11)Amyloidogenic peptide
-
BCC1003
Amyloid β-Protein (1-15)Principal component of amyloid
-
BCC1026
Amyloid β-Peptide (10-20) (human)Initiates neurodegeneration in Alzheimer disease
-
BCC1027
Amyloid Beta-peptide (25-35) (human)Human amyloid β-protein fragment functionally required for neurotoxicity
-
BCC1044
Amyloid Beta-Peptide (12-28) (human)Amyloid β-peptide; minimum required for binding to brain proteins
-
BCC1045
Amyloid Beta-Peptide (1-40) (human)Amyloid β-protein fragment
-
BCC1586
gamma-Secretase ModulatorsAmyloid-β production inhibitor
-
BCC3610
Semagacestat (LY450139)γ-secretase inhibitor
-
BCC3618
DAPT (GSI-IX)γ-secretase inhibitor,potent and specific
-
BCC4035
Frentizole
-
BCC4317
EUK 134Salen-manganese complexes;SOD mimetic
-
BCC6075
EHT 1864Potent inhibitor of Rac family GTPases
-
BCC6113
LPYFD-NH2Binds Aβ; protects from aggregation induced toxicity
-
BCC6293
CRANAD 2
-
BCC6331
Methoxy-X04
-
BCC6360
J 147
-
BCC7351
Ro 90-7501
-
BCC7727
Tramiprosate
-
BCC7821
ColivelinSTAT3 activator. Also protects against β-amyloid neurotoxicity
-
BCC8074
ARN2966APP expression modulator
